Search Results 2111-2120 of 19688 for Hemoglobin

  1. Neurosurgery - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  2. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

    Hemoglobin ≥9 g/dL: transfusion to achieve this cutoff is not allowed within 14 days of first dose of study therapy; 3. Platelet count ≥100,000/mm3; 4 ...

  3. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 - Mayo Clinic

    - Hemoglobin ≥9 g/dL - Left ventricular ejection fraction (LVEF) ≥50% measured by multiple-gated acquisition scan (MUGA) or echocardiogram (ECHO). - It is ...

  4. Orthopedic Surgery - Clinical trials

    ... hemoglobin levels, 90-day complications, readmission and reoperation. A Study to Measure Elbow and Ankle Range-of-Motion via Teleconferencing. Jacksonville ...

  5. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; PT/INR, aPTT ≤ 1.5 x ULN unless participant is receiving a stable dose of therapeutic anticoagulation;; Albumin ≥ 3.0 g/dL ...

  6. Orthopedic Surgery - Clinical trials

    ... hemoglobin levels, 90-day complications, readmission and reoperation. Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With ...

  7. Oral AMXT 1501 Dicaprate in Combination With IV DFMO - Mayo Clinic

    Hemoglobin ≥ 9 g/dL, without transfusion support within 7 days preceding the lab assessment;; Activated partial thromboplastin time/ partial thromboplastin ...

  8. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    Hemoglobin ≥ 8 g/dL or ≥ 5.6 mmol/L. Platelets ≥ 100 x10^9 /L (not achieved by transfusion). Creatinine clearance ≥ 40 mL/min. Participants who are ...

  9. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    Obtained =< 7 days prior to registration: Hemoglobin >= 9 g/dL;; Obtained =< 7 days prior to registration: Total bilirubin =< 1.5 times the upper limit of ...

  10. Special Report

    A1C test — This test, also known as the glycated hemoglobin test, measures the percentage of glucose that's attached to hemoglobin, a protein in red blood cells ...